Abstract: Provided is a work management device including an acquisition unit that acquires information indicating login to a system using a first terminal and an operation history of the first terminal occurring after login to the system, a specifying unit that specifies a non-operation period of a terminal from the operation history of the first terminal, and a calculation unit that calculates working hours including the non-operation period of the terminal according to a length of the non-operation period of the terminal.

Abstract: Provided is a work management device including an acquisition unit that acquires information indicating login to a system using a first terminal and an operation history of the first terminal occurring after login to the system, a specifying unit that specifies a non-operation period of a terminal from the operation history of the first terminal, and a calculation unit that calculates working hours including the non-operation period of the terminal according to a length of the non-operation period of the terminal.

Abstract: An information processing device according to the present application includes a generation unit and a providing unit. The generation unit uses a model that is trained to learn a relationship between a criterion for classifying users of a first company and a criterion for classifying users of a second company to generate a criterion (common key) for classifying the users of the second company into a first category, from the criterion for classifying the users of the first company into the first category. The providing unit provides a criterion generated by the generation unit.

Abstract: Provided is a work management device including an acquisition unit that acquires information indicating login to a system using a first terminal and an operation history of the first terminal occurring after login to the system, a specifying unit that specifies a non-operation period of a terminal from the operation history of the first terminal, and a calculation unit that calculates working hours including the non-operation period of the terminal according to a length of the non-operation period of the terminal.

Abstract: The present invention provides a compound having a PLD inhibitory activity. The present invention provides a compound of the following structural formula, and the like, or a pharmaceutically acceptable salt thereof. wherein each symbol is as defined in the description.

Abstract: A tube is used in fiber-reinforced plastic power transmission shaft. The tube comprises: a cylindrical body section; a connection portion that has a larger diameter than the body section; and an inclined portion that has an outer diameter that increases toward the second connection section from the main body part. The inclined section has formed thereon, a weak section that is damaged when a load input in the axial direction exceeds a prescribed value. With this configuration, the cost of the tube can be reduced, and when a prescribed load is input to the tube in the axial direction, the tube is reliably damaged.

Abstract: Printing apparatus includes a controller is configured to executes holding selection processing of allowing holding in a storage device or deletion from the storage device of a storage of a print job selected by a print job selection processing to be selected by a user's input operation received via the user interface. The print job for which holding of the storage of the print job is selected is stored in the storage device in association with a holding flag. When the holding flag is associated with the print job stored in the storage device, the print job is not deleted from the storage device at a predetermined automatic deletion timing. When the holding flag is not associated with the print job stored in the storage device, the print job is deleted from the storage device at the automatic deletion timing.

Abstract: An information processing device according to the present application includes a generation unit and a providing unit. The generation unit uses a model that is trained to learn a relationship between a criterion for classifying users of a first company and a criterion for classifying users of a second company to generate a criterion (common key) for classifying the users of the second company into a first category, from the criterion for classifying the users of the first company into the first category. The providing unit provides a criterion generated by the generation unit.

Abstract: An information processing device includes: an acquisition unit that collects data on an unspecified large number of users; a generation unit that generates a model for calculating a score of a user group satisfying a predetermined condition by using the data collected; a reception unit that receives designation of a user condition from a business operator on a client side; a calculation unit that calculates a score of a user group satisfying the user condition by using the model; and a providing unit that provides information regarding the score calculated to the business operator.

Abstract: An authentication system acquires, as authentication information, information related to a device, information related to a user or information related to a user terminal, and information indicating that the user or the user terminal is in a vicinity of the device. The authentication system performs authentication of the acquired authentication information, and permits the user for whom or the user terminal for which the authentication is successful to manage the device.

Abstract: A non-transitory computer-readable recording medium includes instructions that cause a computer to execute a process that includes receiving, from a server of a second provider that provides a service for supporting a delivery of a content performed by a first provider, encrypted information along with the content. The first provider encrypts information on the service to obtain the encrypted information. The process also includes attempting decoding the encrypted information, which is received in the receiving, by using a decoding key that is provided by the first provider and determining reliability of the service based on a decoded result in the decoding.

Abstract: A non-transitory computer-readable recording medium includes instructions that cause a computer to execute a process includes receiving, attempting, and determining. The receiving includes receiving, from a server of a second provider that provides a service for supporting a delivery of a content performed by a first provider, encrypted information along with the content. The first provider encrypts information on the service to obtain the encrypted information. The attempting includes attempting decoding the encrypted information, which is received in the receiving, by using a decoding key that is provided by the first provider. The determining includes determining reliability of the service based on a decoded result in the decoding.

Abstract: A distribution apparatus includes a receiving unit and a distributing unit. The receiving unit receives an acquisition request for a first content. The distributing unit distributes the first content displayed with a second content and control information that causes a region of the second content that does not overlap the first content to be displayed in a selectable state and causes a region of the second content overlapping the first content to be displayed so as to overlap the first content in a non-selectable state, when the acquisition request is received by the receiving unit.

Abstract: A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: wherein Z represents nitrogen atom, C—F or the like; R1 represents a C1-C3 alkyl group; Y represents oxygen atom or N—R7; R2, R3, R4, R5, R6 and R7 each independently represents hydrogen atom, a C1-C6 alkyl group, or a group represented by the formula (II): which is used for preventive and/or therapeutic treatment of a disease caused by tau protein kinase 1 hyperactivity such as a neurodegenerative diseases (e.g. Alzheimer disease).

Abstract: A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: wherein Z represents nitrogen atom or C—X; X represents hydrogen atom or fluorine atom; R1 is hydrogen atom or a C1-C3 alkyl group; L represents single bond or a C1-C6 alkylene group which may be substituted; Y represents single bond, sulfur atom, oxygen atom, NH, or the like; R2 represents hydrogen atom or a cyclic group which may be substituted, which is used for preventive and/or therapeutic treatment of a disease caused by abnormal activity of tau protein kinase 1 such as a neurodegenerative diseases (e.g. Alzheimer disease).

Abstract: A distribution apparatus includes a receiving unit and a distributing unit. The receiving unit receives an acquisition request for a first content. The distributing unit distributes the first content displayed with a second content and control information that causes a region of the second content that does not overlap the first content to be displayed in a selectable state and causes a region of the second content overlapping the first content to be displayed so as to overlap the first content in a non-selectable state, when the acquisition request is received by the receiving unit.

Abstract: A pyrimidone derivative represented by general formula (I) or a pharmaceutically acceptable salt thereof: wherein X represents hydrogen atom and Y represents hydroxyl group, or X represents fluorine atom and Y represents hydrogen atom; R1 represents a C1-6 alkyl group; R2 represents a morpholin-4-yl group which may be substituted, or the like, which is used for preventive and/or therapeutic treatment of a disease caused by tau protein kinase 1 hyperactivity such as a neurodegenerative diseases (e.g. Alzheimer disease).

Abstract: A compound represented by the formula (I), an optically active isomer thereof, or a pharmaceutical acceptable salt thereof: wherein R2 represents a hydrogen or the like; R3 represents methyl group or the like; R20 represents a halogen atom or the like; q represents an integer of 0 to 3; Z represent nitrogen atom, CH, or the like; R4 represents hydrogen or the like; R5 represents hydrogen or the like; R6 represents a substituted alkyloxy and the like; p represents an integer of 0 to 3; X represents bond, CH2, oxygen atom, NH, or the like; any one or more of R5 and R6, R5 and R4, R6 and R4, X and R5, X and R4, X and R6, and R6 and R6 may combine to each other to form a ring, which is used for preventive and/or therapeutic treatment of a disease caused by tau protein kinase 1 hyperactivity such as a neurodegenerative diseases (e.g. Alzheimer disease).

Abstract: A pyrimidone derivative represented by general formula (I) or a pharmaceutically acceptable salt thereof: wherein X represents hydrogen atom and Y represents hydroxyl group, or X represents fluorine atom and Y represents hydrogen atom; R1 represents a C1-6 alkyl group; R2 represents a morpholin-4-yl group which may be substituted, or the like, which is used for preventive and/or therapeutic treatment of a disease caused by tau protein kinase 1 hyperactivity such as a neurodegenerative diseases (e.g. Alzheimer disease).

Abstract: A compound represented by the formula (I) or a pharmaceutically acceptable salt thereof: wherein Z represents nitrogen atom or C—X; X represents hydrogen atom or fluorine atom; R1 is hydrogen atom or a C1-C3 alkyl group; L represents single bond or a C1-C6 alkylene group which may be substituted; Y represents single bond, sulfur atom, oxygen atom, NH, or the like; R2 represents hydrogen atom or a cyclic group which may be substituted, which is used for preventive and/or therapeutic treatment of a disease caused by abnormal activity of tau protein kinase 1 such as a neurodegenerative diseases (e.g. Alzheimer disease).